Skip to content
thestock.space

As of 6 Nov 2026, Jubilant Ingrevia trades at 25.9× trailing earnings, above the industry P/E of 22.1×, and the shares are 28% below their 52-week high. Sales and net profit fell 2.9% and 3.3% a year over 3 years; its ROCE of 11% is the second-lowest among the 7 largest Specialty Chemicals peers. Debt is 0.27× equity, and its dividend yield is 0.9%. It is a small-cap company with a market cap of ₹9,030 Cr, ranked 24th of 204 Specialty Chemicals companies by market cap; the shares fell 16% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹581.05
Day high
₹581.05
Day low
₹560.00
Prev. close
₹581.95
Volume
1.9 L

Health check

2 good · 4 to check
  • ReturnsBehind

    −15.7% over a year, better than 0 of 7 peers.

  • Price tagPricier

    P/E 25.9 vs industry 22.1.

  • GrowthShrinking

    Sales −2.9%, profit −3.3% a year over 3 years.

  • ProfitabilityWeak

    ROCE 10.7% vs peer median 24.4%.

  • Balance sheetSolid

    Debt 0.27× equity, interest covered 8.6×, Piotroski 6 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹9,030 Cr, #24 of 204 in its industry by size.

Defensive

Beta 0.30 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹4,924 Cr · profit ₹351 Cr
Market cap
₹9,030 Cr
Small cap
P/E
25.9
Industry 22.1
Price to book
2.72
Peers 13.33
Dividend yield
0.86%
ROE
11.0%
Peers 23.0%
ROCE
10.7%
Peers 24.4%
Debt to equity
0.27
Debt ₹895 Cr
EPS (TTM)
₹22.10
Face value ₹1
OPM (TTM)
14.4%
Net margin 7.1%
Sales growth
+24.4%
Latest quarter vs a year ago
Profit growth
+60.5%
Latest quarter vs a year ago
Price to sales
1.83
EV/EBITDA 13.6

Strengths and risks

Strengths

  • Quarterly profit up 60.5% on a year ago.
  • Quarterly sales up 24.4% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments, Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions…

Headquarters
Noida
Employees
2,185
Sector
Basic Materials
ISIN
INE0BY001018
Website
jubilantingrevia.com

Price range

52 weeks

₹537.30₹795.00

Today

₹560.00₹581.05
Avg volume (3M)
3.8 L
1-year return
minus 15.7%
From 52-week high
minus 28.0%

Analyst consensus

6 analysts
Strong buyMean target ₹905.00 plus 58.1%

Target range, with today’s price

Low ₹649.00High ₹1,200.00

Today’s price ₹572.40 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%16.5%0.094.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.4%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
JUBLINGREAJubilant Ingrevia572.40minus 1.64%9,03025.916.410.7%14.4%0.27−2.9%minus 15.7%
Median of 7 peers–0.48%58,49670.944.424.4%24.4%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Dec 25Mar 26Jun 26Sep 26
1,0291,0401,1661,2891,381
8879131,0031,0901,169
142127163199212
13.8%12.2%13.9%15.5%15.4%
11.29.49.310.29
12.712.511.817.422.5
40.84548.45150.9
–−13–––
99.865.4112141148
24.7%28.3%22.6%24.9%24.7%
75.146.986.4106111
4.752.975.396.687.06

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−2.9%
Profit CAGR 3Y
−3.3%
EPS CAGR 3Y
−3.2%
ROE
11.0%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4,7404,1004,1244,345
–minus 13.5%+0.6%+5.4%
4,1743,6703,5983,756
566430526589
11.9%10.5%12.7%13.5%
14.43230.718.9
20.45254.948.5
122136158175
−1.4−6.4−0.3−13.8
437268344370
29.6%31.7%26.9%24.8%
307183251278
–minus 40.5%+37.3%+10.6%
19.3311.5515.8417.51

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
15.915.815.815.8
2,6502,7222,9113,110
407740764792
1,1861,2541,3411,566
4,2594,7325,0325,484
2,3902,8733,0913,312
558354534164
3.210.314.128
85.282.889.4196
1,2231,4111,3031,784
4,2594,7325,0325,484

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
462430508524
−472−569−393−276
41.6144−129−155
32.25.3−13.592.9
−481−568−366−299
−18.9−138142225
−79.3−78.6−79.8−79.3

Shareholding pattern

Source: NSE filings
45.2%
promoters
  • Promoters45.22%
  • Public53.82%
  • Employee trusts0.96%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202645.22%53.82%0.00
30 Jun 202645.22%53.79%0.00
31 Mar 202645.22%53.79%0.00
31 Dec 202545.22%53.98%0.00
30 Sep 202545.22%53.95%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you